Literature DB >> 10398287

Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests.

P K Andersen1, J P Klein, M J Zhang.   

Abstract

The problem of testing for a centre effect in multi-centre studies following a proportional hazards regression analysis is considered. Two approaches to the problem can be used. One fits a proportional hazards model with a fixed covariate included for each centre (except one). The need for a centre specific adjustment is evaluated using either a score, Wald or likelihood ratio test of the hypothesis that all the centre specific effects are equal to zero. An alternative approach is to introduce a random effect or frailty for each centre into the model. Recently, Commenges and Andersen have proposed a score test for this random effects model. By a Monte Carlo study we compare the performance of these two approaches when either the fixed or random effects model holds true. The study shows that for moderate samples the fixed effects tests have nominal levels much higher than specified, but the random effect test performs as expected under the null hypothesis. Under the alternative hypothesis the random effect test has good power to detect relatively small fixed or random centre effects. Also, if the centre effect is ignored the estimator of the main treatment effect may be quite biased and is inconsistent. The tests are illustrated on a retrospective multi-centre study of recovery from bone marrow transplantation. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10398287     DOI: 10.1002/(sici)1097-0258(19990630)18:12<1489::aid-sim140>3.0.co;2-#

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  61 in total

1.  Estimation in the positive stable shared frailty Cox proportional hazards model.

Authors:  Torben Martinussen; Christian B Pipper
Journal:  Lifetime Data Anal       Date:  2005-03       Impact factor: 1.588

2.  Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

Authors:  S L Gardner; J Carreras; C Boudreau; B M Camitta; R H Adams; A R Chen; S M Davies; J R Edwards; A C Grovas; G A Hale; H M Lazarus; M Arora; P J Stiff; M Eapen
Journal:  Bone Marrow Transplant       Date:  2008-02-04       Impact factor: 5.483

3.  Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Authors:  Hillard M Lazarus; Jeanette Carreras; Christian Boudreau; Fausto R Loberiza; James O Armitage; Brian J Bolwell; César O Freytes; Robert Peter Gale; John Gibson; Gregory A Hale; David J Inwards; Charles F LeMaistre; Dipnarine Maharaj; David I Marks; Alan M Miller; Santiago Pavlovsky; Harry C Schouten; Koen van Besien; Julie M Vose; Jacob D Bitran; Issa F Khouri; Philip L McCarthy; Hongmei Yu; Philip Rowlings; Derek S Serna; Mary M Horowitz; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

4.  Laplace's approximation for relative risk frailty models.

Authors:  Shibao Feng; Lei Nie; Robert A Wolfe
Journal:  Lifetime Data Anal       Date:  2009-01-31       Impact factor: 1.588

5.  Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT.

Authors:  Maria H Gilleece; Myriam Labopin; Bipin N Savani; Ibrahim Yakoub-Agha; Gerard Socié; Tobias Gedde-Dahl; Didier Blaise; Jennifer L Byrne; Charles Craddock; Jan J Cornelissen; William Arcese; Edouard Forcade; Charles Crawley; Emmanuelle Polge; Mohamad Mohty; Arnon Nagler
Journal:  Leukemia       Date:  2019-07-30       Impact factor: 11.528

6.  HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.

Authors:  Ricardo Pasquini; Jeanette Carreras; Marcelo C Pasquini; Bruce M Camitta; Anders L Fasth; Gregory A Hale; Richard E Harris; Judith C Marsh; Anibal J Robinson; Mei-Jie Zhang; Mary Eapen; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

7.  Frailty modelling for survival data from multi-centre clinical trials.

Authors:  Il Do Ha; Richard Sylvester; Catherine Legrand; Gilbert Mackenzie
Journal:  Stat Med       Date:  2011-05-12       Impact factor: 2.373

8.  Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia.

Authors:  Daniel A Keesler; Andrew St Martin; Carmem Bonfim; Adriana Seber; Mei-Jie Zhang; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-22       Impact factor: 5.742

9.  Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.

Authors:  X Cahu; M Labopin; S Giebel; M Aljurf; S Kyrcz-Krzemien; G Socié; M Eder; F Bonifazi; D Bunjes; S Vigouroux; M Michallet; M Stelljes; T Zuckerman; J Finke; J Passweg; I Yakoub-Agha; D Niederwieser; G Sucak; H Sengeløv; E Polge; A Nagler; J Esteve; M Mohty
Journal:  Bone Marrow Transplant       Date:  2015-11-30       Impact factor: 5.483

10.  Differences in clinical trial patient attributes and outcomes according to enrollment setting.

Authors:  Elizabeth B Lamont; Mary Beth Landrum; Nancy L Keating; Laura Archer; Lan Lan; Gary M Strauss; Rogerio Lilenbaum; Harvey B Niell; L Herbert Maurer; Michael P Kosty; Antonius A Miller; Gerald H Clamon; Anthony D Elias; Edward F McClay; Everett E Vokes; Barbara J McNeil
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.